Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy

MeSH terms

• Administration, Oral
• Anticoagulants / therapeutic use
• Atrial Fibrillation* / chemically induced
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Cardiomyopathy, Hypertrophic* / complications
• Cardiomyopathy, Hypertrophic* / drug therapy
• Humans
• Risk Factors
• Thromboembolism* / chemically induced